For The Better

Your 401(k) could be your ticket to years of financial security — if you don’t make these blunders.

The pharma stock announced strong phase 3 results for atogepant in the preventive treatment of episodic migraine.

A little-noticed disclosure in Palantir’s second-quarter earnings report seems odd.

It’s bound to happen eventually, so it’s best to have a contingency plan.

Here’s an important thing for investors in this highflying fintech to remember.

Investors looking for technology-focused businesses need to give these ones a close look.

Here’s one stock to watch in the second half of 2021.

The graphics specialist has more upside to offer thanks to several solid catalysts.

This tiny manufacturer of handheld ultrasound devices has an edge over the competition.

Don’t fight the Fed. These companies can withstand inflation.

The biggest payout increase in nearly four decades could put a lot of extra cash into beneficiaries’ pockets.

They offer more than just great dividends.

The upside potential appears to be much greater for this vaccine stock.

Being patient with these game-changing stocks could lead to life-altering returns.

Complications abound, but they’re not all bad.

Want more money during your senior years? Here’s how to get it.

From luxury goods to secondhand resale, online retailers can do it all. But how are they faring midyear?

If you’re looking to invest a bit of your time in studying public companies, start with these tools.

The majority of investor focus seems to be on the reported drop in monthly active users.

Secular tailwinds can help this tech stock clock faster growth in the coming years.